John S. Montalbano, Director at AbCellera Biologics Inc. (ABCL), bought 20,000 shares at $9.05 ($181K) on 2022-03-01, disclosed to the SEC on 2022-03-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ABCL | BUY | 2025-11-26 | $179K | — | Filing → |
| ABCL | BUY | 2025-03-10 | $115K | — | Filing → |
| ABCL | BUY | 2025-03-07 | $140K | — | Filing → |